"Viruses against cancer"

"Saber Vivir" magazine dedicates an article to a study—co-led by Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, and Raúl Méndez, ICREA researcher at IRB Barcelona—on an innovative approach to provide an adenovirus with high specificity against tumour cells. 

The article includes Raúl Méndez's comments about the effectiveness of this new strategy to achieve genetically modified viruses that infect only tumor cells, thus preserving healthy tissues: "It would be effective in a large number of tumours".